The Vaccine Market Grows Up: They're Not Just for Kids Anymore
Executive Summary
The adult vaccine market is showing more promise than ever before--and is expected to grow about as fast as pediatric vaccines--as more developers focus on diseases that afflict adults disproportionately or simply strike them in large numbers.
You may also be interested in...
Glaxo Buys A Stake In Intercell And Gains Access To Patch Vaccine Techology
As part of the deal, the big drug maker gets the right to market experimental patch vaccines for traveler's diarrhea and pandemic flu.
Glaxo Buys A Stake In Intercell And Gains Access To Patch Vaccine Techology
As part of the deal, the big drug maker gets the right to market experimental patch vaccines for traveler's diarrhea and pandemic flu.
Provenge Scores In Phase III; Will Dendreon Need To Confirm The IMPACT?
Dendreon's release of positive Phase III results for immunotherapeutic Provenge - including a four-month overall survival benefit compared to placebo - begs the question of whether FDA will now approve the prostate cancer vaccine without a confirmatory trial